Medical Litigation News and Research

RSS

Illumina named as defendant in patent infringement suits

Illumina, Inc. (NASDAQ:ILMN) released the following statement by Jay Flatley, its Chief Executive Officer, in response to new patent infringement suits filed yesterday by Affymetrix in Delaware, the United Kingdom and Germany. As of this time, Illumina has yet to be served with these suits.

From Illumina, Inc. 25 Oct 2007

Affymetrix files more patent infringements against Illumina in U.S. and Europe

Affymetrix Inc. has announced that it has filed additional patent infringement lawsuits against Illumina Inc. in the United States District Court for the District of Delaware, in the U.K. High Court of Justice, Chancery Division, Patents Court and in the German, Düsseldorf Regional Court, Patent Division. Affymetrix is seeking all available remedies, including injunctive relief.

From Illumina, Inc. 24 Oct 2007

Mylan settles Paroxetine Hydrochloride patent license with GlaxoSmithKline

Mylan Inc. has announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into a patent license and settlement agreement with GlaxoSmithKline (GSK) relating to Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets, the generic version of GSK's Paxil CR.

24 Oct 2007

Barr Labs and Par Pharmaceutical settle Diazepam patent case with Valeant

Barr Pharmaceuticals, Inc. today announced that its Barr Laboratories, Inc. subsidiary and Par Pharmaceutical Companies, Inc. have entered into a settlement agreement regarding their joint patent challenge with Valeant Pharmaceuticals North America related to Valeant's DIASTAT(R) diazepam rectal gel products.

15 Oct 2007

Alma Lasers responds to Lumenis patent claim

Alma Lasers Ltd. has filed a response denying all Lumenis' patent infringement claims. Alma Lasers will vigorously defend its position.

From Lumenis Inc. 15 Oct 2007

Mylan settles Levetiracetam patent case

Mylan Inc. has announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into an agreement to settle pending litigation with UCB Societe Anonyme and UCB Pharma Inc. (collectively, UCB) relating to Levetiracetam Tablets, 250mg, 500mg and 750mg, the generic version of UCB's Keppra.

4 Oct 2007

Coca-Cola accused of flase claims on Fuze drinks

To hear Coca-Cola tell it, the tea and fruit drinks it sells under its Fuze brand will help you avoid cancer, heart disease, colds, flu, and infections of the lungs and kidneys.

27 Sep 2007

Spectranetics to appeal decision in patent litigation

Spectranetics Corporation today announced it plans to appeal the verdict in a patent litigation dispute with Dr. Peter Rentrop in the U.S. District Court in the Southern District of New York.

13 Sep 2007

$52.5 million settlement against Sepracor approved

Judge Morris E. Lasker of the U.S. District Court for the District of Massachusetts has granted final approval of a $52.5 million settlement in two separate but related securities class actions against Sepracor Inc., a Massachusetts-based pharmaceutical company.

11 Sep 2007

Biota increases damages claim against GlaxoSmithKline

Australian company Biota has filed its updated Particulars of Loss and Damage in its suit against GlaxoSmithKline (GSK) for failing to support the influenza drug, Relenza, discovered by Biota and licensed to GSK in 1990.

31 Jul 2007

Chinese authorities ban AIDS conference

An AIDS conference planned to take place in China in August has been banned by government authorities.

30 Jul 2007

Ranbaxy and GSK agree to settle Valacyclovir U.S. patent case

Ranbaxy Laboratories Limited (RLL) announced today that the Company has reached an agreement with GlaxoSmithKline (GSK) resulting in a dismissal of their U.S. litigation with regard to Valtrex(R) (Valacyclovir Hydrochloride tablets).

27 Jul 2007

BioMedical Enterprises announces patent infringement lawsuit stay ordered

BioMedical Enterprises, Inc. (BME), has announced that on July 20th the Honorable Judge Laura Taylor Swain ordered that all proceedings in the patent infringement lawsuit between BME and InteliFUSE, Inc. be stayed pending the Court's disposition of a motion for summary judgment brought by BME.

27 Jul 2007

Bavarian Nordic and Acambis settle disputes on modified vaccinia Ankara virus

On 25 July 2007, Bavarian Nordic and Acambis reached a global settlement ending the legal disputes between the two companies on matters relating to smallpox vaccines based on the Modified Vaccinia Ankara (MVA) virus.

27 Jul 2007

Claim construction decision issued in Digene's patent case

Digene Corp. has announced that the U.S. District Court for the Western District of Wisconsin issued a pre-trial claim construction decision in the pending litigation between Digene and Third Wave Technologies, Inc. In that litigation, Digene alleges that Third Wave infringes its U.S. Patent No. 5,643,715 covering probes and methods for detecting human papillomavirus (HPV) type 52, a high-risk type of HPV.

26 Jul 2007

Court dismisses Gen-Probe court action against Digene

Digene Corp. has announced that a California state court has dismissed a complaint filed against the company by Gen-Probe, Inc., without option to amend. Gen-Probe's complaint asked the court to declare that an agreement between Gen-Probe and F. Hoffman-LaRoche Ltd.

23 Jul 2007

Ortho-McNeil settles patent cases against Par/Kali

Ortho-McNeil, Inc. has announced that it settled its patent litigation against Par Pharmaceutical Companies, Inc. and its subsidiaries, Par Pharmaceutical, Inc., and Kali Laboratories, Inc., generic drug manufacturers, regarding their infringement of the Ortho-McNeil patent for ULTRACET (tramadol/acetaminophen).

20 Jul 2007

New genomics-based technology

Bruce S. Gillis, M.D., M.P.H., a medical toxicologist and CEO of the research group, The Cytokine Institute, will present a tutorial on a new genomics-based technology, msds1(TM).

16 Jul 2007

Boston Scientific to settle product lawsuits

Boston Scientific Corporationhas announced that an agreement has been reached to settle claims associated with a series of product communications issued by Guidant Corporation in 2005 and 2006. Boston Scientific acquired Guidant Corporation last year.

16 Jul 2007

Anti-smoking ads revealing tobacco industry's deceptive practices have been aggressively quashed

Anti-smoking ads that reveal the tobacco industry's deceptive practices have been aggressively quashed through various methods found Temple University Assistant Professor Jennifer K. Ibrahim, co-author of an analysis in the August issue of the American Journal of Public Health.

12 Jul 2007